Phase Focus
Financials
Estimates*
USD | 2011 | 2012 | 2013 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m | <1m | 1.1m |
% growth | - | 76 % | 37 % | - | - | - | 110 % |
EBITDA | (<1m) | (<1m) | (1.2m) | - | - | - | - |
% EBITDA margin | (532 %) | (452 %) | (462 %) | - | - | - | - |
Profit | (<1m) | (<1m) | (1.2m) | - | - | - | - |
% profit margin | (562 %) | (474 %) | (470 %) | - | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
$1.2m | Early VC | ||
$570k | Seed | ||
$5.0m | Early VC | ||
N/A | Grant | ||
* | £5.0m Valuation: £10.4m | Late VC | |
* | N/A | Acquisition | |
Total Funding | $13.4m |
Related Content
Recent News about Phase Focus
EditPhasefocus Limited specializes in Quantitative Phase Imaging (QPI) technology, providing advanced solutions for cell analysis and engineering metrology. The company serves clients in the life sciences and engineering sectors, offering tools that automatically characterize cell growth, morphology, and motility using state-of-the-art single cell tracking algorithms. Phasefocus operates in a niche market, leveraging its patented Virtual Lens technology to eliminate geometric restrictions and image infidelities imposed by traditional physical focusing devices. This technology is applicable across multiple wavelength regimes, including visible light, X-ray, and electron imaging. The business model is centered around selling and supporting its imaging systems, which are used in research and development settings. Revenue is generated through the sale of these systems, as well as ongoing support and maintenance services.
Keywords: Quantitative Phase Imaging, cell analysis, engineering metrology, Virtual Lens, single cell tracking, life sciences, morphology, motility, imaging systems, patented technology.